"Fluvoxamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.
| Descriptor ID |
D016666
|
| MeSH Number(s) |
D02.092.570.665.250
|
| Concept/Terms |
Luvox- Luvox
- Floxyfral
- Fevarin
- Dumirox
- Faverin
|
Below are MeSH descriptors whose meaning is more general than "Fluvoxamine".
Below are MeSH descriptors whose meaning is more specific than "Fluvoxamine".
This graph shows the total number of publications written about "Fluvoxamine" by people in this website by year, and whether "Fluvoxamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 2 | 0 | 2 |
| 1994 | 1 | 1 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluvoxamine" by people in Profiles.
-
DeVane CL, Ware MR, Emmanuel NP, Brawman-Mintzer O, Morton WA, Villarreal G, Lydiard RB. Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia. Int Clin Psychopharmacol. 1999 Nov; 14(6):345-51.
-
Tancer ME, Uhde TW. Role of serotonin drugs in the treatment of social phobia. J Clin Psychiatry. 1997; 58 Suppl 5:50-4.
-
Markowitz JS, Gill HS, Lavia M, Brewerton TD, DeVane CL. Fluvoxamine-clozapine dose-dependent interaction. Can J Psychiatry. 1996 Dec; 41(10):670-1.
-
Brady KT, Lydiard RB, Kellner CH, Joffe R, Laird LK, Morton WA, Steele TE. A comparison of the effects of imipramine and fluvoxamine on the thyroid axis. Biol Psychiatry. 1994 Dec 01; 36(11):778-9.
-
Jackson CW, Morton WA, Lydiard RB. Pharmacologic management of obsessive-compulsive disorder. South Med J. 1994 Mar; 87(3):310-21.
-
Laird LK, Lydiard RB, Morton WA, Steele TE, Kellner C, Thompson NM, Ballenger JC. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients. J Clin Psychiatry. 1993 Jun; 54(6):224-8.
-
Johnson MR, Lydiard RB, Morton WA, Laird LK, Steele TE, Kellner CH, Ballenger JC. Effect of fluvoxamine, imipramine and placebo on catecholamine function in depressed outpatients. J Psychiatr Res. 1993 Apr-Jun; 27(2):161-72.
-
Lydiard RB, Laird LK, Morton WA, Steele TE, Kellner C, Laraia MT, Ballenger JC. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression. Psychopharmacol Bull. 1989; 25(1):68-70.